BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21682918)

  • 1. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression.
    McConnell BV; Koto K; Gutierrez-Hartmann A
    Mol Cancer; 2011 Jun; 10():75. PubMed ID: 21682918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
    Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals.
    Thirkettle HJ; Girling J; Warren AY; Mills IG; Sahadevan K; Leung H; Hamdy F; Whitaker HC; Neal DE
    Clin Cancer Res; 2009 May; 15(9):3003-13. PubMed ID: 19383828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of manipulation on cartilage in rats with knee osteoarthritis based on the Rho-associated protein kinase/LIM kinase 1/Cofilin signaling pathways.
    Xiao G; Yunhao Y; Dongmei L; Fang P; Zhixue Y; Zhengwei Z; Ao L; Chenglin T
    J Tradit Chin Med; 2022 Apr; 42(2):194-199. PubMed ID: 35473339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.
    Bagheri-Yarmand R; Mazumdar A; Sahin AA; Kumar R
    Int J Cancer; 2006 Jun; 118(11):2703-10. PubMed ID: 16381000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.
    Prescott JD; Poczobutt JM; Tentler JJ; Walker DM; Gutierrez-Hartmann A
    Mol Cancer; 2011 Aug; 10():103. PubMed ID: 21871131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
    Zhou Y; Su J; Shi L; Liao Q; Su Q
    Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM kinase 1 modulates opsonized zymosan-triggered activation of macrophage-like U937 cells. Possible involvement of phosphorylation of cofilin and reorganization of actin cytoskeleton.
    Matsui S; Matsumoto S; Adachi R; Kusui K; Hirayama A; Watanabe H; Ohashi K; Mizuno K; Yamaguchi T; Kasahara T; Suzuki K
    J Biol Chem; 2002 Jan; 277(1):544-9. PubMed ID: 11694543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
    Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
    Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein.
    Oksayan S; Wiltzer L; Rowe CL; Blondel D; Jans DA; Moseley GW
    J Biol Chem; 2012 Aug; 287(33):28112-21. PubMed ID: 22700958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.
    Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S
    Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.
    Akkiprik M; Hu L; Sahin A; Hao X; Zhang W
    BMC Cancer; 2009 Apr; 9():103. PubMed ID: 19341485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small GTPase RhoA regulates the LIMK1/2-cofilin pathway to modulate cytoskeletal dynamics in oocyte meiosis.
    Duan X; Zhang Y; Chen KL; Zhang HL; Wu LL; Liu HL; Wang ZB; Sun SC
    J Cell Physiol; 2018 Aug; 233(8):6088-6097. PubMed ID: 29319181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear export of LIM-kinase 1, mediated by two leucine-rich nuclear-export signals within the PDZ domain.
    Yang N; Mizuno K
    Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):793-8. PubMed ID: 10051454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIM kinase 1 and cofilin regulate actin filament population required for dynamin-dependent apical carrier fission from the trans-Golgi network.
    Salvarezza SB; Deborde S; Schreiner R; Campagne F; Kessels MM; Qualmann B; Caceres A; Kreitzer G; Rodriguez-Boulan E
    Mol Biol Cell; 2009 Jan; 20(1):438-51. PubMed ID: 18987335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.
    Mardilovich K; Gabrielsen M; McGarry L; Orange C; Patel R; Shanks E; Edwards J; Olson MF
    Mol Cancer Ther; 2015 Jan; 14(1):246-58. PubMed ID: 25344584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.